加味逍遥散对非糜烂性反流病肝郁脾虚证患者血管活性肠肽及促生长素水平的影响
Research of Jiawei-Xiaoyao powder on the Ghrelin, VIP for the non-erosive reflux disease with stagnation of liver Qi and spleen deficiency type
摘要目的 探讨加味逍遥散对肝郁脾虚型非糜烂性反流病(non-erosive reflux disease,NERD)患者促生长素、血管活性肠肽(vasoaetive intestinal peptide,VIP)水平的影响.方法 将符合入选标准的70例肝郁脾虚型NERD患者按随机数字表法分为2组,每组35例.治疗组口服加味逍遥散免煎颗粒,对照组口服奥美拉唑肠溶片与多潘立酮片.2组均治疗8周.采用ELISA法检测血浆促生长素、VIP含量.结果 治疗后,治疗组血浆促生长素水平[(210.96±16.85) pg/ml比(195.75±12.62) pg/ml,t=4.274]高于对照组(P<0.01),血浆VIP水平[(16.12±1.41) pg/ml比(18.57±2.68) pg/ml,t=4.786]低于对照组(P<0.01).结论 加味逍遥散可降低NERD患者血浆VIP水平,升高血浆促生长素水平,有效减缓NERD病程.
更多相关知识
abstractsObjective To investigate the effect of Jiawei-Xiaoyao powder on the levels of somatotropin and vasoaetive intestinal peptide (VIP) in patients with non-erosive reflux disease (NERD).Methods Seventy patients with liver-stagnation and spleen-deficiency NERD who met the inclusion criteria were divided into two groups according to the random number table,35 in each group.The treatment group was orally administered with Jiawei-Xiaoyao powder,and the control group was given oral omeprazole enteric-coated tablets and domperidone.Both groups were treated for 8 weeks.Plasma somatotropin and VIP levels were measured by ELISA.Results After treatment,plasma somatotropin levels (210.96 ± 16.85 pg/ml vs.195.75 ± 12.62 pg/ml,t=4.274) in the treatment group were significantly higher than that in the control group (P<0.01),and plasma VIP level (16.12 ± 1.41 pg/ml vs.18.57 ± 2.68 pg/ml,t=4.786) in the treatment group was significantly lower than that in the control group (P<0.01).Conclusions The Jiawei-Xiaoyao powder could reduce plasma VIP level in NERD patients,increase plasma somatotropin levels of NERD.
More相关知识
- 浏览96
- 被引3
- 下载24

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文